In adult cohorts with chronic kidney disease, scholars have found that CRP exacerbated anemia by inhibiting endogenous/exogenous erythropoietin (38, 39), which may contribute to a synergic effect between inflammation and anemia on unfavorable events (39). This evidence concerns the gene EPO and chronic kidney disease.